It is worth mentioning that there have been previous reports of deregulations (mutations and copy number losses) observed in PARK2 in GBM (Veeriah et al., 2010), which argue in favor of a possible tumor suppressor function of this gene in such tumors. This evidence concerns the gene PRKN and neoplasm.